Form 483

Robert Bolan, M.D. Form 483, 2017-04-28

FDA issued a Form 483 to Robert Bolan, M.D. on 2017-04-28 with 2 public-safe observations.

483· Form 483 issuedHuman Drugs2 observations

Robert Bolan, M.D. · Los Angeles, United States · Issued April 28, 2017

Overview

  • 2 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

28 Apr 2017
21 CFR 312.60

FD-1572, protocol compliance

Cited by Raymond W Brullo

28 Apr 2017
21 CFR 312.62(b)

Case history records- inadequate or inadequate

Cited by Raymond W Brullo

Inspected site

RBRobert Bolan, M.D.Los Angeles, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 312.60Cited across public-safe Form 483 observations1x
21 CFR 312.62(b)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 2 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere